Scholarlink

Background <p>Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, chronic hyperglycemia, and oxidative stress. Recent research has highlighted the therapeutic potential of gut microbiota-derived metabolites in regulating glucose homeostasis.</p> Aim <p>This study evaluated the antidiabetic effects of indole propionic acid (IPA) in a streptozotocin-induced diabetic rat model.</p> Method <p>Male Wistar rats (<i>n</i> = 30) were divided into Control, T2DM, T2DM + IPA, T2DM+metformin, and IPA-only groups. Following four weeks of oral IPA administration, biochemical, histological, molecular, and metabolomic assessments were performed.</p> Results <p>IPA treatment significantly reduced fasting blood glucose levels, improved body weight, and normalized food intake in diabetic rats. Histopathological analysis revealed that IPA preserved pancreatic islet architecture and increased both islet cell counts and diameter. Furthermore, IPA markedly enhanced antioxidant defenses by elevating superoxide dismutase (SOD) and catalase (CAT) activities while reducing malondialdehyde (MDA) content in pancreatic tissue. Molecular analysis showed that IPA upregulated the expression of key insulin signaling genes—PI3K, Akt, and GLUT4—in skeletal muscle and downregulated mTOR expression in pancreatic tissue, indicating improved insulin sensitivity. Molecular docking suggested a potential direct interaction between IPA and GLUT4/PI3K, supporting the gene expression data.</p> Conclusion <p>These findings highlight the multifaceted antidiabetic potential of IPA, supporting its use as a promising therapeutic agent for managing T2DM and its associated metabolic dysfunctions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Therapeutic role of gut microbial metabolite indole propionic acid in a rat model of high-fat diet/Streptozotocin-Induced diabetes: enhancing glucose metabolism, antioxidant defense and PI3K/Akt/GLUT4 signaling pathway

  • 期刊论文

  • 发表日期：

    2026年2月18日

查看全文
  • Nayab Shuja,
  • Imran Tarique,
  • Sehrish Sohail,
  • Iram Taalay

摘要

Background

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, chronic hyperglycemia, and oxidative stress. Recent research has highlighted the therapeutic potential of gut microbiota-derived metabolites in regulating glucose homeostasis.

Aim

This study evaluated the antidiabetic effects of indole propionic acid (IPA) in a streptozotocin-induced diabetic rat model.

Method

Male Wistar rats (n = 30) were divided into Control, T2DM, T2DM + IPA, T2DM+metformin, and IPA-only groups. Following four weeks of oral IPA administration, biochemical, histological, molecular, and metabolomic assessments were performed.

Results

IPA treatment significantly reduced fasting blood glucose levels, improved body weight, and normalized food intake in diabetic rats. Histopathological analysis revealed that IPA preserved pancreatic islet architecture and increased both islet cell counts and diameter. Furthermore, IPA markedly enhanced antioxidant defenses by elevating superoxide dismutase (SOD) and catalase (CAT) activities while reducing malondialdehyde (MDA) content in pancreatic tissue. Molecular analysis showed that IPA upregulated the expression of key insulin signaling genes—PI3K, Akt, and GLUT4—in skeletal muscle and downregulated mTOR expression in pancreatic tissue, indicating improved insulin sensitivity. Molecular docking suggested a potential direct interaction between IPA and GLUT4/PI3K, supporting the gene expression data.

Conclusion

These findings highlight the multifaceted antidiabetic potential of IPA, supporting its use as a promising therapeutic agent for managing T2DM and its associated metabolic dysfunctions.